Also trades as: ABDX.L (LSE) · $vol 0M
ABDXF OTC
Abingdon Health Plc
1W: +0.7%
1M: -3.7%
3M: +6.3%
YTD: +105.0%
1Y: +105.0%
$0.14
-0.00 (-1.37%)
Weekly Expected Move ±2.1%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$3M
-91.8% ▼
Capital Expenditures
$346K
-743.9% ▼
5Y CAGR: -26.9%
Free Cash Flow
-$4M
-107.5% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$478K
+126.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$7M | -$21M | -$3M | -$1M | -$3M |
| Depreciation & Amort. | $749K | $2M | $673K | $426K | $608K |
| Stock-Based Comp. | $1M | $231K | $28K | $48K | $214K |
| Change in Working Capital | -$8M | -$5M | $4M | -$744K | -$542K |
| Other Non-Cash Items | $11M | $26M | $80K | -$118K | -$47K |
| Operating Cash Flow | -$13M | -$8M | $1M | -$2M | -$3M |
| — Investing Activities — | |||||
| Capital Expenditures | -$7M | -$760K | -$75K | -$35K | -$327K |
| Acquisitions (Net) | -$24K | $0 | $0 | $0 | -$1M |
| Investment Purchases | $0 | $0 | $0 | -$13K | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$482K | -$74K | $8K | $25K | $81K |
| Investing Cash Flow | -$7M | -$760K | -$67K | -$23K | -$1M |
| — Financing Activities — | |||||
| Net Debt Issuance | $251K | $42K | -$6K | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$213K | -$263K | -$1K | -$114K | -$545K |
| Financing Cash Flow | $21M | $6M | -$7K | -$114K | $5M |
| Net Change in Cash | $589K | -$3M | $839K | -$2M | $478K |
| Cash End of Period | $5M | $2M | $3M | $1M | $2M |
| Free Cash Flow | -$20M | -$8M | $845K | -$2M | -$4M |